EUVIMEDEUVIMED entdecken
LeserbriefKommentar

HER2-positive apocrine carcinoma of the breast and PIK3CA mutations

Semir Vranic

Breast Cancer · 2026-07 · 33 (4) · 945-946

DOI: 10.1007/s12282-026-01872-1 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Breast Cancer, online erschienen am 20.05.2026. Verfasst von Semir Vranic. Beteiligte Einrichtung: College of Medicine, QU Health, Qatar University, Doha, 2713, Qatar. semir.vranic@gmail.com. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • College of Medicine, QU Health, Qatar University, Doha, 2713, Qatar. semir.vranic@gmail.com.

Zitieren

APA

Vranic, S. (2026). HER2-positive apocrine carcinoma of the breast and PIK3CA mutations. Breast Cancer, 33(4), 945-946. https://doi.org/10.1007/s12282-026-01872-1

Vancouver

Vranic S. HER2-positive apocrine carcinoma of the breast and PIK3CA mutations. Breast Cancer. 2026;33(4):945-946. doi:10.1007/s12282-026-01872-1

BibTeX
@article{Vranic2026,
  author = {Vranic, Semir},
  title = {HER2-positive apocrine carcinoma of the breast and PIK3CA mutations},
  journal = {Breast Cancer},
  year = {2026},
  volume = {33},
  number = {4},
  pages = {945--946},
  doi = {10.1007/s12282-026-01872-1}
}
Kostenlos starten →